Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Caribou Biosciences (CRBU) Return on Sales (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Return on Sales for 6 consecutive years, with 7.22% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 1150.0% to 7.22% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13.29% through Dec 2025, up 338.0% year-over-year, with the annual reading at 13.27% for FY2025, 165.0% up from the prior year.
  • Return on Sales for Q4 2025 was 7.22% at Caribou Biosciences, up from 13.38% in the prior quarter.
  • The five-year high for Return on Sales was 0.62% in Q3 2023, with the low at 18.94% in Q1 2024.
  • Average Return on Sales over 5 years is 10.8%, with a median of 8.82% recorded in 2023.
  • The sharpest move saw Return on Sales plummeted -1827bps in 2024, then soared 1150bps in 2025.
  • Over 5 years, Return on Sales stood at 7.22% in 2021, then fell by -15bps to 8.28% in 2022, then decreased by -27bps to 10.52% in 2023, then crashed by -78bps to 18.72% in 2024, then skyrocketed by 61bps to 7.22% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 7.22%, 13.38%, and 17.84% for Q4 2025, Q3 2025, and Q2 2025 respectively.